Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Proteasome02:18

The Proteasome

8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Regulated Protein Degradation02:58

Regulated Protein Degradation

7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome Structure01:17

The Proteasome Structure

735
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
735

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prognostic Value of Echocardiographic TAPSE/PASP Ratio-Defined RV-PA Uncoupling in Cardiovascular and NonCardiovascular Diseases.

JACC. Asia·2026
Same author

Corrigendum to "Association of serum 25-hydroxyvitamin D with the risk of depression in individuals with prediabetes and diabetes: A prospective cohort study" [J Nutr Health Aging, 29 (2025) 100556].

The journal of nutrition, health & aging·2026
Same author

Dysregulation of the HSF1-Mediated UPR<sup>mt</sup> Pathway in Colonic Smooth Muscle Cells Drives Motility Dysfunction in Functional Constipation.

Biomolecules·2026
Same author

NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation.

Frontiers in immunology·2026
Same author

<i>Dendrobium officinale</i> polysaccharide ameliorates high-fat diet-induced hepatic lipid metabolic disorder via the SIRT6/PGC-1α signaling axis.

Frontiers in nutrition·2026
Same author

Structure characterization assists rational design of polyethyleneglycol diglycidyl ether (PEGDE) substituted hyaluronic acid.

Synthetic and systems biotechnology·2026

相关实验视频

Updated: Jun 24, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.6K

阶段分离增强的PROTAC用于高效的蛋白质降解.

Xiaolin Yu1, Wenrui Hu1, Hang Dong1

  • 1State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Biomacromolecules
|June 3, 2024
PubMed
概括

基于相分离的PROTACs (PSETACs) 通过形成细胞液滴来增强蛋白质降解. 这种通过mRNA-LNP提供的新方法为向蛋白质降解提供了一个有前途的治疗策略.

更多相关视频

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

相关实验视频

Last Updated: Jun 24, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.6K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 生物宏分子冷凝剂通过相分离提高生物过程效率.
  • 向蛋白质分解的仿真体 (PROTACs) 是针对蛋白质降解的有效工具.
  • 目前的PROTAC技术可以改进,用于增强治疗应用.

研究的目的:

  • 设计利用相位分离促进蛋白质降解的 PROTAC.
  • 研究相分离增强型PROTACs (PSETACs) 在降解标蛋白中的有效性.
  • 为PSETACs使用mRNA-LNP建立一种新的细胞内传递方法,以潜在的治疗用途.

主要方法:

  • 将一个内在无序区域纳入 PROTAC,以诱导相位分离 (PSETAC).
  • 评估PSETAC诱导的目标蛋白滴滴形成和细胞中的降解效率.
  • 使用核向域用于核蛋白降解与PSETAC.
  • 通过脂质纳米粒子封装的mRNA (mRNA-LNP) 进行PSETAC的细胞内传递.

主要成果:

  • 与标准的PROTAC相比,PSETACs形成了 protein滴,显著提高了降解效率.
  • 具有核向域的PSETACs成功降解了核蛋白.
  • 使用mRNA-LNP进行PSETAC的细胞内输送使内源蛋白降解成为可能.

结论:

  • 通过生物宏分子相分离,PSETACs代表了一种通过生物宏分子相分离来增强蛋白质降解的新策略.
  • 该PSETAC mRNA-LNP方法提供了一个潜在的可翻译和安全的治疗方法.
  • 这项技术有望开发基于PROTACs的各种疾病的新临床应用.